The following drug products were reviewed and acted upon by the CDPHP Pharmacy and Therapeutics Committee on October 1, 2008.
Review the full CDPHP Clinical Formulary which includes tier status, prior authorization requirements and quantity limits for select drugs.
Also see Medicare Drug Formulary and Medicare Formulary Updates.
| Drug | New Tier / Formulary Status | Previous Tier / Formulary Status |
| acarbose tablets (generic of Precose) | 1* | New to market |
| Actonel with Calcium packs (risedronate sodium tablets with calcium carbonate tablets) | 3 | 2, preferred |
| Azelex cream (azelaic acid) | 3 | 2 |
| bupropion extended-release tablets 150mg (generic of Wellbutrin XL) | 1, preferred | New to market |
| calcipotriene topical solution (generic of Dovonex topical scalp solution) | 1 | New to market |
| Cimzia lyophilized powder for solution for injection (certolizumab pegol) | Medical Benefit, PA, SP | New to market |
| Crestor tablets (rosuvastatin) | 2, preferred (effective 1/1/09) | 3 |
| divalproex sodium delayed-release tablets (generic of Depakote) | 1 | New to market |
| Dovonex topical scalp solution (calcipotriene) | 3** | 2 |
| dronabinol capsules (generic of Marinol) | 1 | New to market |
| eplerenone tablets (generic of Inspra) | 1 | New to market |
| epoprostenol sodium for injection (generic of Flolan) | Medical Benefit | New to market |
| Fusilev injection (levoleucovorin for injection) | Medical Benefit | New to market |
| galantamine tablets (generic of Razadyne) | 1 | New to market |
| Inspra tablets (eplerenone) | 3** | 2 |
| lamotrigine tablets (generic of Lamictal) | 1 | New to market |
| Liquadd oral solution (dextroamphetamine sulfate) | 3 | New to market |
| Luvox CR capsules (fluvoxamine controlled-release) | 3, excluded | New to market |
| Marinol capsules (dronabinol) | 3** | 2 |
| mycophenolate mofetil capsules (generic of CellCept) | 1 | New to market |
| nisoldipine extended-release tablets (generic of Sular) | 1 | New to market |
| Ocella tablets (ethinyl estradiol/drospirenone), (generic of Yasmin) | 1, preferred | New to market |
| omeprazole delayed-release capsules 20mg (generic of Prilosec) | qty of #30 capsules per 30 days (cumulative by class) | qty of #60 capsules per 30 days (cumulative by class) |
| pantoprazole sodium delayed-release tablets (generic of Protonix) | 1, preferred ##,ST (effective 1/1/09) | 1, preferred ## |
| paroxetine HCl sustained-release tablets (generic of Paxil CR) | 1, preferred | New to market |
| Patanase nasal spray (olopatadine) | 3 | New to market |
| Paxil CR tablets (paroxetine HCl sustained-release) | 3** | 2, preferred |
| Precose tablets (acarbose) | 3* (brand only) | 2* |
| Proventil HFA inhalation (albuterol) | 3 | 2, preferred |
| QVAR inhalation (beclomethasone dipropionate) | 2, preferred | 3, excluded |
| Razadyne tablets (galantamine) | 3** | 2 |
| Relistor subcutaneous injection (methylnaltrexone bromide) | 3 | New to market |
| Requip tablets (ropinirole HCl) | 3** | 2 |
| Requip XL tablets (ropinirole extended-release) | 3 | New to market |
| risperidone tablets (generic of Risperdal) | 1 | New to market |
| Ritalin LA capsules (methylphenidate extended-release) | 3 | 2 |
| ropinirole HCl tablets (generic of Requip) | 1 | New to market |
| Simcor tablets (niacin extended-release/simvastatin) | 3 | New to market |
| Singulair tablets/chewable tablets/oral granules (montelukast sodium) | 2, preferred, ST (effective 1/1/09) | 2, preferred |
| Solodyn tablets (minocycline extended-release) | 3, excluded, PA | 3, excluded |
| Tazorac gel; cream (tazarotene) | 3 | 2 |
| Treanda injection (bendamustine HCl) | Medical Benefit | New to market |
| Treximet tablets (sumatriptan/naproxen sodium) | 3^ | New to market |
| Ventolin HFA inhalation (albuterol) | 2, preferred | 3 |
| Vytorin tablets (ezetimibe/simvastatin) | 3 (effective 1/1/09) | 2, preferred |
| Xibrom ophthalmic solution (bromfenac) | 2 | 3 |
| Yasmin tablets (ethinyl estradiol/drospirenone) | 3** | 2, preferred |
| zaleplon capsules (generic of Sonata) | 1# | New to market |
| Zamicet solution (hydrocodone/APAP) | 3 | New to market |
The drug names listed here are the registered and/or unregistered trademarks of third-party pharmaceutical companies unrelated to and unaffiliated with CDPHP. These trademarked brand names are included here for informational purposes only and are not intended to imply or suggest any affiliation between CDPHP and such third-party pharmaceutical companies.